Cardiac Imaging: Page 223

Toshiba debuts new Infinix version
By AuntMinnie.com staff writers
Toshiba America Medical Systems has introduced Infinix VF-i/SP, a cardiovascular x-ray system designed to handle both diagnostic and interventional procedures.
March 25, 2007
Johns Hopkins develops x-ray system to track stem cells
By AuntMinnie.com staff writers
Researchers at Johns Hopkins University in Baltimore have developed a new technique that transports therapeutic stem cells in a multilayer microcapsule to protect the cells from being attacked by the body's immune system, while enabling them to be seen on x-ray.
March 25, 2007
Cardiac CT drives adoption of 3D visualization
By Cynthia E. Keen
Clinical demands for faster processing, more automated processes, and greater precision is driving the development and adoption of 3D software, especially for cardiac CT. And the increasing use of 3D advanced visualization software is changing workflow processes, requiring clinicians to learn new workstation software and develop new interpretation skills, and perhaps even changing the relationship between radiologists and cardiologists.
March 25, 2007
Cook launches MiraFlex microcatheter
By AuntMinnie.com staff writers
Interventional firm Cook has introduced a new microcatheter, MiraFlex, designed for use with its embolization products.
March 21, 2007
TomTec to expand into MRI
By AuntMinnie.com staff writers
Ultrasound visualization developer TomTec Imaging Systems is moving into MRI. The firm is previewing its left ventricular (LV) analysis software for cardiac applications at the American College of Cardiology (ACC) meeting in New Orleans.
March 20, 2007
McKesson, Toshiba expand partnership
By AuntMinnie.com staff writers
Healthcare information technology firm McKesson and Toshiba America Medical Systems are expanding their partnership with a new agreement for Toshiba to offer McKesson's Horizon Cardiology Hemo product with Toshiba's Infinix vascular x-ray systems.
March 20, 2007
GRAPPA MRA curtails gadolinium dose in peripheral arterial occlusive disease
By Shalmali Pal
Using a parallel acquisition technique can reduce the amount of gadolinium needed for intra-arterial MRI, according to Swiss imaging experts. Furthermore, a high contrast-to-noise ratio (CNR) can be achieved in the vessel lumen, they wrote in the American Journal of Roentgenology.
March 20, 2007
2007 03 19 13 57 08 706
Pie to release new CAAS software
By AuntMinnie.com staff writers
Dutch imaging firm Pie Medical Imaging will be unveiling the latest version of its CAAS quantitative analysis software at the upcoming annual scientific sessions of the American College of Cardiology (ACC).
March 19, 2007
CardioStream adds client
By AuntMinnie.com staff writers
Cardiac image management firm CardioStream has inked a deal with Children's Healthcare of Atlanta and the Sibley Heart Center.
March 19, 2007
1.5T, 3.0T MRI are equivalent for assessing myocardial infarction
By Eric Barnes
In a new study by researchers from the U.K., 1.5- and 3.0-tesla MRI showed strong agreement in both mass and transmural extent of myocardial hyperenhancement (HE) when using the same imaging sequence for patients with previous myocardial infarction.
March 14, 2007
Reconstruction kernel dramatically affects stent evaluation
By Eric Barnes
VIENNA - If the results of a phantom study are valid in patients, the choice of reconstruction kernel with 64-slice CT has a critical impact on coronary artery stent evaluations. And as Dr. Florian Wolf explained at today's cardiac imaging sessions at the European Congress of Radiology (ECR), the evaluation of stents for detecting restenosis is critical for patient outcomes.
March 10, 2007
2007 03 11 09 56 31 706
Coronary CTA saves money in intermediate-risk individuals
By Eric Barnes
VIENNA - Studies continue to show the value of coronary CT angiography (CTA) in individuals at high risk of coronary artery disease, but its value in individuals at intermediate risk is unclear. Now researchers of a new study, presented at the European Congress of Radiology (ECR), report that CTA is not only warranted for individuals in the middle of the Framingham risk profile, but that it saves money compared to other diagnostic modalities.
March 9, 2007
Previous Page
Page 223 of 325
Next Page